Sign In
Buy ABSI
$5.94
-0.410 (-6.46%)
At Close: Jun 03, 2026
Absci to Participate in Upcoming Investor Conferences
08:00am, Wednesday, 20'th May 2026
VANCOUVER, Wash. and NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generativ
Absci Corporation (ABSI) Q1 2026 Earnings Call Transcript
08:01am, Friday, 08'th May 2026
Absci Corporation (ABSI) Q1 2026 Earnings Call Transcript
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates
11:26pm, Thursday, 07'th May 2026
Absci Corporation (ABSI) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.2. This compares to a loss of $0.21 per share a year ago.
Absci Reports Business Updates and First Quarter 2026 Financial and Operating Results
04:05pm, Thursday, 07'th May 2026
Successfully dosed all four planned healthy volunteer SAD cohorts of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data Preliminary pharmacokinetic (PK) modeling fro
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08:11pm, Monday, 04'th May 2026
VANCOUVER, Wash. and NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generativ
Absci to Report Business Updates and First Quarter 2026 Financial and Operating Results on May 7, 2026
04:05pm, Thursday, 23'rd Apr 2026
VANCOUVER, Wash. and NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generat
Absci Corporation (ABSI) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
03:40pm, Tuesday, 21'st Apr 2026
Absci Corporation (ABSI) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference
08:00am, Wednesday, 08'th Apr 2026
VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generat
MiMedx Group (NASDAQ:MDXG) & Absci (NASDAQ:ABSI) Head to Head Analysis
01:22am, Thursday, 02'nd Apr 2026
MiMedx Group (NASDAQ: MDXG - Get Free Report) and Absci (NASDAQ: ABSI - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based
Absci Q4 Earnings Call Highlights
03:07am, Thursday, 26'th Mar 2026
Absci (NASDAQ: ABSI) provided a fourth-quarter and full-year 2025 business update on Monday, highlighting early progress for lead candidate ABS-201, expansion into a second indication, and continued i
Absci: Downgrade To 'Hold' As ABS-101 On Back Burner And Pivot To ABS-201
02:48pm, Wednesday, 25'th Mar 2026
Absci Corporation is downgraded to Hold due to a lack of differentiation for ABS-101 and a strategic pivot to ABS-201. ABS-101 failed to outperform 2nd-generation TL1A candidates, leading to halted in
Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript
08:54pm, Tuesday, 24'th Mar 2026
Absci Corporation (ABSI) Q4 2025 Earnings Call Transcript
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
06:26pm, Tuesday, 24'th Mar 2026
Absci Corporation (ABSI) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.16. This compares to a loss of $0.25 per share a year ago.
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
04:05pm, Tuesday, 24'th Mar 2026
Successfully dosed first three cohorts in SAD portion of ongoing ABS-201™ HEADLINE trial; well-tolerated with favorable emerging safety data
Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
04:22am, Monday, 23'rd Mar 2026
Absci Corporation (ABSI) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript
